The landscape of cancer treatment has been profoundly reshaped by the emergence of immunotherapy, a paradigm-shifting approach that harnesses the power of the body's own immune system to fight cancer. At the forefront of this revolution is pembrolizumab immunotherapy, marketed under the brand name Keytruda, and the broader class of PD-1 checkpoint inhibitors. These innovative...